BiOrigin
Thomas Sandal is an accomplished biotechnology executive with extensive experience in leadership roles across multiple companies. Currently serving as Chief Development Officer at Blue Cell Therapeutics, Thomas is integral in funding strategy and clinical trial support. As Entrepreneur in Residence at BiOrigin, Thomas aids Engimmune Therapeutics AG in implementing IND enabling activities. Prior positions include Chief Technology Officer at PokeAcell, where Thomas managed CMC and supply chain projects, and VP Process Development at AGC Biologics, overseeing a large team and strategic direction. Thomas also held significant roles at MICROBIOTICA LIMITED, Crescendo Biologics Ltd, Pieris AG, GlaxoSmithKline, Domantis Ltd, and CMC Biologics, contributing to advancements in biopharmaceutical development and regulatory strategies. Educational background includes degrees from DTU - Technical University of Denmark and Copenhagen University College of Engineering.
This person is not in any offices
BiOrigin
BiOrigin provides different types of strategic and operational support to companies and projects in order to help them steer through the critical start-up and subsequent growth phase.